Revolution Medicines, Inc.
RVMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $217 | $402 | $334 | $543 |
| Short-Term Investments | $1,714 | $1,735 | $1,769 | $1,746 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $46 | $39 | $32 | $38 |
| Total Curr. Assets | $1,977 | $2,176 | $2,135 | $2,328 |
| Property Plant & Equip (Net) | $167 | $147 | $143 | $142 |
| Goodwill | $15 | $15 | $15 | $15 |
| Intangibles | $56 | $56 | $56 | $57 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $37 | $35 | $17 | $18 |
| Total NC Assets | $274 | $253 | $231 | $231 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,252 | $2,430 | $2,365 | $2,558 |
| Liabilities | – | – | – | – |
| Payables | $75 | $57 | $48 | $54 |
| Short-Term Debt | $16 | $13 | $13 | $13 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $154 | $115 | $98 | $97 |
| Total Curr. Liab. | $246 | $185 | $159 | $164 |
| LT Debt | $142 | $120 | $121 | $123 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $2 | $2 | $2 |
| Other NC Liab. | $267 | $258 | $5 | $4 |
| Total NC Liab. | $409 | $380 | $129 | $129 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $158 | $133 | $134 | $136 |
| Total Liabilities | $655 | $564 | $287 | $293 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,504 | -$2,199 | -$1,951 | -$1,738 |
| AOCI | $3 | $1 | $2 | $1 |
| Other Equity | $4,098 | $4,063 | $4,028 | $4,002 |
| Total Equity | $1,597 | $1,865 | $2,078 | $2,265 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,252 | $2,430 | $2,365 | $2,558 |
| Net Debt | -$59 | -$270 | -$199 | -$407 |